NCT00333424View on ClinicalTrials.gov

Thai Prophylactic HIV Vaccine Phase I Study

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2009

Conditions
HIV
Interventions
BIOLOGICAL

pHIS-HIV-AE (DNA vaccine) prime and rFPV-HIV-AE (recombinant fowlpox virus boost) vaccine

6mg pHIS-HIV-AE at weeks 0, 4 and 8; 3 x 10e8 pfu/mL rFPV-HIV-AE at week 12

Trial Locations (1)

10330

HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
collaborator

Thai Red Cross AIDS Research Centre

OTHER

lead

Kirby Institute

OTHER_GOV